Pacific Pediatric Neuro-oncology Consortium Foundati is a 501(c)(3) organization based in San Rafael, California, registered in 2014, with $1,840,562 in FY2024 revenue. CharityIndex grades it B.
Revenue (FY2024)
$1.8M
▼ 19.2% vs prior year
Medical Research median: $217K
Expenses (FY2024)
$1.8M
Net assets
$1.1M
Employees
—
Rated on 2 of 4 criteria — the rest aren't reported in this filing type.
Held down by its weakest criterion — a strong score on one criterion can't hide a weak one.
How the rating works →Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. Not scored for Pacific Pediatric Neuro-oncology Consortium Foundati— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Pacific Pediatric Neuro-oncology Consortium Foundati: 8 mo reserves · +2% margin earns a A on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. Not scored for Pacific Pediatric Neuro-oncology Consortium Foundati— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Pacific Pediatric Neuro-oncology Consortium Foundati: 2 of 5 disclosure signals earns a C on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Revenue grew from $0 (FY2013) to $1.8M (FY2024) across 12 reported years.
Financial snapshot
Operating margin
2.2%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$1.2M
Total liabilities
$47K
Net assets
$1.1M
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $1,840,562▼19.2% | $1,799,386▼3.5% | $1,127,579▲3.8% | $1,175,030▲4.6% | 990 |
| 2023 | $2,276,608▼4.7% | $1,865,564▼6.1% | $1,086,361▲60.9% | $1,123,817▲65.2% | 990 |
| 2022 | $2,387,852▲129% | $1,986,124▲95.9% | $675,317▲147% | $680,478▲149% | 990 |
| 2021 | $1,042,173▲162% | $1,014,007▲88.3% | $273,589▲11.5% | $273,589▲10.8% | 990 |
| 2020 | $397,440▼50.9% | $538,640▲3.6% | $245,423▼36.5% | $246,976▼36.1% | 990 |
| 2019 | $808,871▲213% | $519,856▲17.4% | $386,623▲296% | $386,623▲296% | 990 |
| 2018 | $258,353▼14.4% | $442,862▲123% | $97,608▼65.4% | $97,608▼65.4% | 990 |
| 2017 | $301,652▲305% | $198,202▲478% | $282,117▲57.9% | $282,117▲57.9% | 990 |
| 2016 | $74,519▼59.6% | $34,320▼70.4% | $178,667▲29.0% | $178,667▲29.0% | 990EZ |
| 2015 | $184,595▲164% | $116,098 | $138,468▲97.9% | $138,468▲97.9% | 990EZ |
| 2014 | $69,971 | $0 | $69,971 | $69,971 | 990EZ |
| 2013 | $0 | $0 | $0 | $0 | 990EZ |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
32 grants to Pacific Pediatric Neuro-oncology Consortium Foundati totaling $2.9M, reported by foundations on their Schedule I filings — showing the 15 most recent.
Explore more
Data for Pacific Pediatric Neuro-oncology Consortium Foundati (EIN 46-3152273) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.